The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global CBD food and beverage market is expected to exhibit a CAGR of 26.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Cannabidiol (CBD) refers to a non-psychoactive derivative of cannabis that is extracted from leaves, resins, and flowers of marijuana or hemp plant. CBD is primarily infused with several food items and beverages based on its antioxidant and neuroprotective properties. As a result, these edible products help in treating numerous health conditions, such as anxiety, osteoporosis, insomnia, inflammation, hyperemesis, etc. CBD food and beverages are considered to be the healthier alternatives of smoking cannabis as they mitigate the exposure to tar and carcinogens. Some of the CBD-infused edible products that are widely available in the market include chocolates, bakery items, gummies, tea, snacks, ice cream, etc.
The growing legalization of recreational cannabis across several countries, such as the United States, Canada, Mexico, etc., is primarily driving the market for CBD food and beverages. Furthermore, the rising shift from smoking cannabis towards healthier edible alternatives based on the high prevalence of several respiratory ailments is also propelling the market growth. Additionally, the wide availability of CBD-infused beverages, such as cannabis cola, fruit punch, coffee, tea, etc., across various legal marijuana dispensaries, is further augmenting the global market. Apart from this, the growing adoption of CBD-infused edible products for treating poor appetite, weight loss, nausea, and muscle spasms, in cancer patients is also catalyzing the market growth. Moreover, the increasing popularity of CBD protein bars among athletes and sportspersons has led to the elevating product demand in the sports nutrition sector. Numerous innovations pertaining to the micro-dosing of cannabis have led to the introduction of alcohol-free beer brewed from CBD, which are further expected to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global CBD food and beverage market report, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on source, product type and distribution channel.
Breakup by Source:
Breakup by Product Type:
Breakup by Distribution Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Alkaline88 LLC, Beverages Trade Network, Dixie Brands Inc., Green Roads (Affinity Beverage Group, Inc.), Kannaway LLC, Koios Beverage Corp., Lagunitas Brewing Company (Heineken N.V.), NaturalXtract, New Age Beverages Corporation and The Supreme Cannabis Company Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Source, Product Type, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, United Kingdom, Netherlands, Spain, China, South Korea, Australia, Brazil, Argentina, South Africa, Israel|
|Companies Covered||Alkaline88 LLC, Beverages Trade Network, Dixie Brands Inc., Green Roads (Affinity Beverage Group, Inc.), Kannaway LLC, Koios Beverage Corp., Lagunitas Brewing Company (Heineken N.V.), NaturalXtract, New Age Beverages Corporation and The Supreme Cannabis Company Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at